Mckesson Corp
NYSE:MCK
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
562.78
888.4524
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
MCK
stock under the Base Case scenario is
1 284.92
USD.
Compared to the current market price of 808.8 USD,
Mckesson Corp
is
Undervalued by 37%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Mckesson Corp.
| US |
|
Cencora Inc
NYSE:COR
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
|
| AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
McKesson’s heavy reliance on large pharmaceutical manufacturers and payers could result in margin pressures if partners consolidate or aggressively negotiate prices, hurting profitability.
Potential disruptions to McKesson’s supply chain, particularly in generic drug procurement, risk creating unexpected shortages or higher costs that cannot be easily passed on to customers.
Regulatory scrutiny over pharmaceutical distribution practices, including opioid handling, may lead to costly legal settlements or additional compliance requirements, eroding earnings.
The company’s massive distribution scale and long-standing relationships with healthcare providers position McKesson to weather competitive pressures and maintain stable margins.
McKesson’s strategic focus on technology solutions, such as advanced analytics and supply chain software, could unlock incremental revenue streams and reinforce customer loyalty.
Expanding specialty drug distribution, including oncology and specialty therapies, provides a higher-margin growth avenue that could meaningfully boost McKesson’s profitability over time.
Revenue & Expenses Breakdown
Mckesson Corp
Balance Sheet Decomposition
Mckesson Corp
| Current Assets | 59.9B |
| Cash & Short-Term Investments | 4B |
| Receivables | 28.3B |
| Other Current Assets | 27.6B |
| Non-Current Assets | 24.3B |
| Long-Term Investments | 119m |
| PP&E | 4.6B |
| Intangibles | 15.5B |
| Other Non-Current Assets | 4B |
| Current Liabilities | 68B |
| Accounts Payable | 60.9B |
| Accrued Liabilities | 5.3B |
| Other Current Liabilities | 1.7B |
| Non-Current Liabilities | 17.9B |
| Long-Term Debt | 6B |
| Other Non-Current Liabilities | 11.9B |
Free Cash Flow Analysis
Mckesson Corp
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Mckesson Corp
|
Revenue
|
387.1B
USD
|
|
Cost of Revenue
|
-373.7B
USD
|
|
Gross Profit
|
13.4B
USD
|
|
Operating Expenses
|
-8.3B
USD
|
|
Operating Income
|
5.2B
USD
|
|
Other Expenses
|
-1.2B
USD
|
|
Net Income
|
4B
USD
|
MCK Profitability Score
Profitability Due Diligence
Mckesson Corp's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
Score
Mckesson Corp's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
MCK Solvency Score
Solvency Due Diligence
Mckesson Corp's solvency score is 66/100. The higher the solvency score, the more solvent the company is.
Score
Mckesson Corp's solvency score is 66/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MCK Price Targets Summary
Mckesson Corp
According to Wall Street analysts, the average 1-year price target for
MCK
is 937.87 USD
with a low forecast of 647.65 USD and a high forecast of 1 050 USD.
Dividends
Current shareholder yield for
MCK is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
MCK
stock under the Base Case scenario is
1 284.92
USD.
Compared to the current market price of 808.8 USD,
Mckesson Corp
is
Undervalued by 37%.